drugset
drugset / Trial / NCT01301677

Ultra Violet B Radiation (UVR) Study of Strontium Chloride Hexahydrate Hydrocortisone

NCT01301677 ↗

Phase 1 Completed 47 enrolled X-pert Med GmbH
RandomizedSingle-groupDouble-blindTreatment

Summary

Double blinded (subject and observer), randomised, active (hydrocortisone (HC)) controlled study of the effect of strontium chloride hexahydrate on ultraviolet B radiation (UVR) induced signs of inflammation (erythema and pain) in healthy volunteers.

Timeline

Start
2011-01
Primary completion
2011-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hydrocortisone Other / unclassified — Topical
Subject strontium chloride hexahydrate Unknown 10 % Topical

Indications

No indication recorded.